The abstract is read at the publisher; the summary is JClub's.
Gba1 F213I point mutation mice show more severe dopaminergic neuron loss in the substantia nigra pars compacta, linked to increased Lcn2 expression.
- Why it matters: GBA1 mutations in sporadic Parkinson’s disease are associated with earlier onset and worse phenotypes, but the molecular pathway driving neurodegeneration is unclear.
- What they did: In an MPTP-induced model and multiple Gba1 mutant mouse lines, brain transcript and protein analyses identified significant Lcn2 upregulation, which was also induced by AAV9 GBA1 L444P expression and GBA1 knockdown in neuro-derived cells.
- The result: Recombinant Lcn2 protein increased α-synuclein accumulation and dopaminergic neuron loss in the SNpc, while Lcn2 knockout alleviated MPTP-induced neuron loss in Gba1 F213I/+ and GBA1 L444P-expressing mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.